We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+9.34%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$9.03B
AUM Growth
+$6.6B
Cap. Flow
+$1.53B
Cap. Flow %
16.94%
Top 10 Hldgs %
64.29%
Holding
5,395
New
546
Increased
3,017
Reduced
1,240
Closed
466

Sector Composition

Rank Sector Weight
1 Technology 6.44%
2 Industrials 4.65%
3 Healthcare 4.47%
4 Consumer Discretionary 4.32%
5 Financials 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KRUS icon
3551
Kura Sushi USA
KRUS
$637M
$49K ﹤0.01%
3,748
+2,670
+248% +$33.5K
RGNX icon
3552
Regenxbio
RGNX
$704M
$49K ﹤0.01%
1,793
-4,512
-72% -$147K
UAA icon
3553
Under Armour
UAA
$2.3B
$49K ﹤0.01%
4,337
+704
+19% +$7.41K
CCJ icon
3554
Cameco
CCJ
$42.6B
$48K ﹤0.01%
4,779
+3,237
+210% +$35K
DBO icon
3555
Invesco DB Oil Fund
DBO
$387M
$48K ﹤0.01%
6,700
+3,700
+123% +$27.3K
GIB icon
3556
CGI
GIB
$15.3B
$48K ﹤0.01%
704
-1,537
-69% -$105K
MLSS icon
3557
Milestone Scientific
MLSS
$48.9M
$48K ﹤0.01%
34,783
+33,036
+1,891% +$57.6K
VLDR
3558
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$48K ﹤0.01%
+2,563
New +$50.3K
PFNX
3559
DELISTED
Pfenex Inc.
PFNX
$48K ﹤0.01%
3,722
-8,273
-69% -$87.5K
ADPT icon
3560
Adaptive Biotechnologies
ADPT
$3.89B
$47K ﹤0.01%
974
-632
-39% -$26.6K
BBU
3561
DELISTED
Brookfield Business Partners
BBU
$47K ﹤0.01%
2,429
+2,373
+4,238% +$46.4K
GLDM icon
3562
SPDR Gold MiniShares Trust
GLDM
$29.8B
$47K ﹤0.01%
1,263
-33,131
-96% -$1.26M
TS icon
3563
Tenaris
TS
$26.6B
$47K ﹤0.01%
4,770
-10,302
-68% -$122K
CNTG
3564
DELISTED
Centogene N.V. Common Shares
CNTG
$47K ﹤0.01%
4,918
+3,499
+247% +$44.5K
AERI
3565
DELISTED
Aerie Pharmaceuticals
AERI
$47K ﹤0.01%
3,968
-774
-16% -$9.43K
LFC
3566
DELISTED
China Life Insurance Company Ltd.
LFC
$47K ﹤0.01%
+4,136
New +$49.5K
SINA
3567
DELISTED
Sina Corp
SINA
$47K ﹤0.01%
1,098
-3,442
-76% -$138K
AUDC icon
3568
AudioCodes
AUDC
$249M
$46K ﹤0.01%
1,475
+939
+175% +$31.8K
EUM icon
3569
ProShares Trust Short MSCI Emerging Markets
EUM
$9.27M
$46K ﹤0.01%
1,490
-1,160
-44% -$36.2K
HEDJ icon
3570
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.88B
$46K ﹤0.01%
+1,494
New +$46.5K
LYRA
3571
DELISTED
LYRA THERAPEUTICS INC
LYRA
$46K ﹤0.01%
82
+66
+413% +$41K
MYGN icon
3572
Myriad Genetics
MYGN
$303M
$46K ﹤0.01%
3,561
-17,867
-83% -$226K
PGX icon
3573
Invesco Preferred ETF
PGX
$3.77B
$46K ﹤0.01%
+3,099
New +$45.5K
YUMC icon
3574
Yum China
YUMC
$16.2B
$46K ﹤0.01%
864
+441
+104% +$23.3K
ONC
3575
BeOne Medicines Ltd
ONC
$40.6B
$46K ﹤0.01%
162
-39
-19% -$9.17K

Similar funds

Tower Research Capital (TRC)'s Q3 2020 Portfolio in Review

As of Q3 2020, Tower Research Capital (TRC) held 5,395 positions worth $9.03B, up 271% from $2.44B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Tower Research Capital (TRC) deployed $1.53B of net new capital in Q3 2020, opening 546 new positions and adding to 3,017 existing holdings. Its largest new stake was iShares Biotechnology ETF: 34,723 shares worth $4.7M.

By sector, the portfolio is most concentrated in Technology at 6.4% of assets, down from 12% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Vanguard S&P 500 ETF, an estimated $38.5M trimmed.

  • Tower Research Capital (TRC)'s largest Q3 2020 buy was iShares Biotechnology ETF: 34,723 shares worth $4.7M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q3 2020, an estimated $487M increase.
  • Tower Research Capital (TRC)'s biggest Q3 2020 reduction was Vanguard S&P 500 ETF, cutting an estimated $38.5M.
  • Tower Research Capital (TRC) fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2020, selling an estimated $51.8M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 64% of its $9.03B portfolio in Q3 2020.
  • Tower Research Capital (TRC) opened 546 new positions and closed 466 in Q3 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 271% quarter-over-quarter to $9.03B.

Based on Tower Research Capital (TRC)'s 13F filing for Q3 2020, filed 16 Nov 2020.